These findings show that circ-PITHD1 is a promising biomarker in CRC diagnostics, which will extend drug applications targeting circ-PITHD1 and indicates a role for circ-PITHD1 in CRC treatment. The gene discussed is PITHD1; the disease is colorectal carcinoma.